RT @RichardPAConway: JAK-pot registry-based study. Following JAKi failure should you switch mode of action or go to seco
Tweet Content
JAK-pot registry-based study. Following JAKi failure should you switch mode of action or go to second JAKi? Both seem equally effective in terms of drug retention. Didn't matter if switch for efficacy or adverse event. Abstr#1442 #ACR21 @RheumNow https://t.co/QEBB3flArC
Show on Archive Page
On
Display in Search Results
On
PDQ
Off